Stay updated on Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial page.

Latest updates to the Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1.0%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check45 days agoChange DetectedThe webpage has undergone significant updates, including the addition of detailed classifications of renal cell carcinoma and the identification of key collaborators such as Exelixis and the National Cancer Institute. Additionally, the revision number has been updated to v2.15.0.SummaryDifference62%
- Check53 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and changed the date from 2025-03-25 to 2025-01-09.SummaryDifference0.3%
- Check60 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial page.